Page last updated: 2024-10-25

deferoxamine and Anti-GBM Disease

deferoxamine has been researched along with Anti-GBM Disease in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clajus, C1
Becker, JU1
Stichtenoth, DO1
Wortmann, J1
Schwarz, A1
Kielstein, JT1
Stacher, A1

Reviews

1 review available for deferoxamine and Anti-GBM Disease

ArticleYear
[Diseases caused by iron metabolism disorders and their therapy].
    Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1969, Volume: 50, Issue:3

    Topics: Adult; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Bloodletting; Deferoxamine; D

1969

Other Studies

1 other study available for deferoxamine and Anti-GBM Disease

ArticleYear
Acute kidney injury due to deferoxamine in a renal transplant patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:3

    Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Anti-Glomerular Basement Membrane Disease; Defer

2008